NCT03514589View on ClinicalTrials.gov

NeSST2: The Development of a Noninvasive Short Synacthen Test

PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 12, 2012

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Adrenal Suppression
Interventions
DRUG

nasal Tetracosactide

Bioavailability of nasal synacthen compared to IV comparator

DRUG

IV tetracosactide

Bioavailability of nasal synacthen compared to IV comparator

Trial Locations (1)

S10 2TH

RECRUITING

Sheffield Children's NHS Foundation Trust, Sheffield

All Listed Sponsors
lead

Sheffield Children's NHS Foundation Trust

OTHER